Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
The effect of inhaled corticosteroids on bronchoalveolar lavage interleukin-8 levels and cell percentage in stable chronic obstructive pulmonary disease patients Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001
Longitudinal evaluation of airway inflammation in stable CF patients by bronchoalveolar lavage (BAL) and influence of rhDNAse Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002
The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Iron and lipid content in serum and alveolar macrophages obtained by bronchoalveolar lavage in experimental pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001
Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis Source: Eur Respir J 2001; 17: 716-722 Year: 2001
Evaluation of upper airway involvement and interleukin-8 levels in nasal lavage fluid of stable COPD patients Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Pre-procedure antibiotics and effect on microbiological yield from broncho-alveolar lavage fluid in children with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011
Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia Year: 2020
Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL Source: Eur Respir J 2003; 22: 497-502 Year: 2003
Levels of interferon-γ and interleukin-2 receptor-α for bronchoalveolar lavage fluid were correlated with clinical grade and treatment course of pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001